Atlas Trials

Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction

Clinical trial NCT05139472 · COMPLETED

Trial details

NCT number
NCT05139472
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure with Preserved Ejection FractionHeart Failure, DiastolicDiabetes Mellitus
Start date
2021-11-09
Primary completion
2023-09-20
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.